Details for Patent: 11,612,658
✉ Email this page to a colleague
Which drugs does patent 11,612,658 protect, and when does it expire?
Patent 11,612,658 protects VERKAZIA and is included in one NDA.
This patent has forty-four patent family members in eighteen countries.
Drugs Protected by US Patent 11,612,658
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | 11,612,658 | ⤷ Subscribe | FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN AND ADULTS | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,612,658
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2049079 | ⤷ Subscribe | PA2017003 | Lithuania | ⤷ Subscribe |
| European Patent Office | 2049079 | ⤷ Subscribe | LUC00006 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 2049079 | ⤷ Subscribe | PA2017003,C2049079 | Lithuania | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
